Tarsons Products Limited (NSEI: TARSONS)
Health Care · Life Sciences Tools & Services · IN
Rs320.95
-2.57% today · +7.7% 1Y
Tarsons Products Limited (NSEI: TARSONS) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $176.45M and employs 1,108 people.
Over the last twelve months the share price has gained 7.7%, trading between 164.45 and 375.00.
Tweenvest scores Tarsons Products Limited across four factors: quality 71/100, value 36/100, growth 24/100. Its strongest factor is quality.
TARSONS price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $176.45M
- Revenue (TTM)
- $46.68M
- P/E
- 154.77
- EPS
- 2.07
- Dividend yield
- —
- Beta (5Y)
- 0.30
- 52-week high
- Rs375.00
- 52-week low
- Rs164.45
- Avg volume (3M)
- —
- Shares outstanding
- 53.21M
- Employees
- 1,108
- Next earnings
- —
About Tarsons Products Limited
Established in 1983 and headquartered in Kolkata, India, Tarsons Products Limited specializes in the global manufacturing and distribution of plastic laboratory supplies and scientific instruments. The company's diverse product portfolio features disposable plastic labware, centrifuge and cryogenic equipment, liquid handling systems, and safety products. Its comprehensive catalog further encompasses items such as bottles, carboys, measuring cylinders, cell culture products, electrophoresis apparatus, microscopy and microbiology tools, vacuum desiccators, mini coolers, cryo boxes, beakers, test tube racks, pipette tips, petri dishes, centrifuge tubes, cryogenic and storage vials, Pasteur pipettes, and vortex mixers, among many others. These offerings are vital for research and applications across various scientific disciplines including molecular biology, cell culture, genomics, proteomics, and immunology.
- ISIN
- INE144Z01023
- Founded
- 1983
- Listed since
- Nov 26, 2021
- Exchange
- National Stock Exchange of India
- Currency
- INR
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Lifecore Biomedical, Inc.NasdaqGS: LFCR | $244.15M | $6.45 | -0.08% |
| Dishman Carbogen Amcis LimitedNSEI: DCAL | $242.48M | Rs149.68 | -0.45% |
| Diaceutics PLCAIM: DXRX | $228.03M | £2.03 | -0.25% |
| Windlas Biotech LimitedNSEI: WINDLAS | $202.39M | Rs949.20 | -12.31% |
| Fine Foods & Pharmaceuticals N.T.M. S.p.A.BIT: FF | $168.81M | €6.62 | -1.19% |
| BICO Group AB (publ)OM: BICO | $167.28M | Skr23.90 | +0.84% |
| Vitrafy Life Sciences LimitedASX: VFY | $165.37M | AU$3.11 | -12.64% |
| BLS Pharmaceuticals LimitedASX: BLS | $163.93M | AU$1.02 | -0.97% |
Figures last refreshed Oct 11, 2026.